{"version":"1.0","provider_name":"Times South Africa","provider_url":"https:\/\/timessouthafrica.com","author_name":"TSA","author_url":"https:\/\/timessouthafrica.com\/author\/tsa\/","title":"Grifols \u00e9tend son activit\u00e9 en Afrique en signant un accord pour la cr\u00e9ation d\u2019une usine de fabrication de solutions intraveineuses au Nigeria - Times South Africa","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"eJxyfDrytT\"><a href=\"https:\/\/timessouthafrica.com\/grifols-etend-son-activite-en-afrique-en-signant-un-accord-pour-la-creation-dune-usine-de-fabrication-de-solutions-intraveineuses-au-nigeria\/\">Grifols \u00e9tend son activit\u00e9 en Afrique en signant un accord pour la cr\u00e9ation d\u2019une usine de fabrication de solutions intraveineuses au Nigeria<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/timessouthafrica.com\/grifols-etend-son-activite-en-afrique-en-signant-un-accord-pour-la-creation-dune-usine-de-fabrication-de-solutions-intraveineuses-au-nigeria\/embed\/#?secret=eJxyfDrytT\" width=\"600\" height=\"338\" title=\"&#8220;Grifols \u00e9tend son activit\u00e9 en Afrique en signant un accord pour la cr\u00e9ation d\u2019une usine de fabrication de solutions intraveineuses au Nigeria&#8221; &#8212; Times South Africa\" data-secret=\"eJxyfDrytT\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script>\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n<\/script>\n","description":"\u2013 Il sera construit par Grifols Engineering, une r\u00e9f\u00e9rence mondiale dans le d\u00e9veloppement et la construction d\u2019installations de production avanc\u00e9es pour les industries de la sant\u00e9 et de la biotechnologie \u2013 L\u2019usine sera op\u00e9rationnelle en 2024 et produira 5,5\u00a0millions de poches de solutions intraveineuses (IV) par an pour le propri\u00e9taire de l\u2019usine, Dozie and Dozie\u2019s [\u2026]","thumbnail_url":"https:\/\/ci6.googleusercontent.com\/proxy\/EcMu26aDRJqvqP1Y6bhEa-e83OqLbQH44T5OG11bfhZ3cnXNswt7ru2qwNA96tuLMSnKADMhvWZrEWv2giHyEgMVR8sYr5UH4dzT=s0-d-e1-ft#https:\/\/mma.prnewswire.com\/media\/463444\/Grifols_Logo.jpg"}